Assignee
ADAMAS PHARMA LLC
US·11 granted patents·7 pending applications·111 citations·filing 2014–2021
Top patents by PatentIndex Score
18 records- 0198US10646456B2Methods of administering amantadineADAMAS PHARMA LLC·Filed 2018·Granted May 12, 2020·34 cites·58 claims
- 0296US9877933B2Method of administering amantadine prior to a sleep periodADAMAS PHARMA LLC·Filed 2017·Granted Jan 30, 2018·15 cites·31 claims
- 0396US9867793B2Method of administering amantadine prior to a sleep periodADAMAS PHARMA LLC·Filed 2017·Granted Jan 16, 2018·15 cites·43 claims
- 0496US9867791B2Method of administering amantadine prior to a sleep periodADAMAS PHARMA LLC·Filed 2017·Granted Jan 16, 2018·17 cites·56 claims
- 0596US9867792B2Method of administering amantadine prior to a sleep periodADAMAS PHARMA LLC·Filed 2017·Granted Jan 16, 2018·15 cites·19 claims
- 0692US10154971B2Methods of administering amantadineADAMAS PHARMA LLC·Filed 2014·Granted Dec 18, 2018·8 cites·56 claims
- 0788US11197835B2Method of administering amantadine prior to a sleep periodADAMAS PHARMA LLC·Filed 2019·Granted Dec 14, 2021·2 cites·16 claims
- 0887US11077073B2Methods of using amantadine compositionsADAMAS PHARMA LLC·Filed 2019·Granted Aug 3, 2021·2 cites·11 claims
- 0987US11065213B2Amantadine compositions and preparations thereofADAMAS PHARMA LLC·Filed 2019·Granted Jul 20, 2021·2 cites·9 claims
- 1086US11903908B2Methods of administering amantadineADAMAS PHARMA LLC·Filed 2020·Granted Feb 20, 2024·1 cites·46 claims
- 1172US2018263928A1Amantadine compositions and methods of useADAMAS PHARMA LLC·Filed 2018·Application pending·0 cites
- 1271US12233033B2Amantadine compositions, preparations thereof, and methods of useADAMAS PHARMA LLC·Filed 2021·Granted Feb 25, 2025·0 cites·34 claims
- 1371US2017281565A1Composition for Administering an NMDA Receptor Antagonist to a SubjectADAMAS PHARMA LLC·Filed 2016·Application pending·0 cites
- 1470US2018263914A1Compositions for the treatment of cns-related conditionsADAMAS PHARMA LLC·Filed 2017·Application pending·0 cites
- 1566US2022211641A1Composition and method for treating neurological diseaseADAMAS PHARMA LLC·Filed 2021·Application pending·0 cites
- 1663US2019201354A1Composition for administering an nmda receptor antagonist to a subjectADAMAS PHARMA LLC·Filed 2019·Application pending·0 cites
- 1753US2019328684A1Composition and method for treating neurological diseaseADAMAS PHARMA LLC·Filed 2018·Application pending·0 cites
- 1849US2019008799A1Composition for administering an nmda receptor antagonist to a subjectADAMAS PHARMA LLC·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →